Survival disparities by age and country of diagnosis for patients with acute leukemia.
about
Targeting the TAM Receptors in LeukemiaThe MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia.Frontline treatment of acute myeloid leukemia in adults.Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.
P2860
Survival disparities by age and country of diagnosis for patients with acute leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@en
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@nl
type
label
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@en
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@nl
prefLabel
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@en
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@nl
P2093
P2860
P1433
P1476
Survival disparities by age and country of diagnosis for patients with acute leukemia.
@en
P2093
Dianne Pulte
Maria Theresa Redaniel
Mona Jeffreys
P2860
P304
P356
10.3109/10428194.2015.1014358
P577
2015-02-11T00:00:00Z